tiprankstipranks
Advertisement
Advertisement
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
PremiumThe FlyTenax Therapeutics reports Q1 EPS (35c), consensus (40c)
1M ago
Tenax Therapeutics appoints Timothy Healey as chief commercial officer
Premium
The Fly
Tenax Therapeutics appoints Timothy Healey as chief commercial officer
2M ago
Tenax Therapeutics Names New CFO to Support Growth
Premium
Company Announcements
Tenax Therapeutics Names New CFO to Support Growth
2M ago
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyTenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
3M ago
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
3M ago
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany AnnouncementsTenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
6M ago
Tenax Therapeutics reports result of prespecified blinded sample size assessment
Premium
The Fly
Tenax Therapeutics reports result of prespecified blinded sample size assessment
6M ago
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100